• NSC 87877: Shp2 Inhibitor Workflows for Neuroinflammation St

  2026-05-25

  NSC 87877, a potent and selective Shp2 inhibitor, empowers precise dissection of neuroinflammatory pathways and targeted modulation in both in vitro and in vivo models. With robust selectivity, reproducible solubility, and translational support from emerging stroke research, it stands out as an advanced tool for mechanistic and therapeutic studies.

• Myriocin and SPT Inhibition: Strategic Leverage in Translati

  2026-05-25

  This thought-leadership article synthesizes mechanistic insights and translational strategy for researchers investigating sphingolipid metabolism and its clinical implications. It specifically explores Myriocin’s role as a potent, selective serine palmitoyltransferase inhibitor, illuminating its impact on oncology, immunology, and cardiovascular research. By integrating pivotal findings from recent cardiac remodeling studies and advanced workflow guides, this piece positions Myriocin as a critical enabler for bridging basic science and therapeutic innovation, while distinguishing itself from standard product literature.

• JNJ-10198409: Precision Platelet-Derived Growth Factor Recep

  2026-05-24

  JNJ-10198409 sets a benchmark for selective PDGF-BB receptor inhibition, empowering angiogenesis and tumor biology researchers with nanomolar efficacy and robust workflow control. Its ATP-competitive action translates into reliable, reproducible suppression of PDGF-driven proliferation and angiogenesis, with tailored protocols for in vitro and in vivo models.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Use G

  2026-05-23

  Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) is designed to prevent protein degradation during extraction and sample preparation, especially when downstream applications are sensitive to divalent cations. It is not suitable for workflows requiring metalloprotease inhibition via EDTA or where DMSO is incompatible.

• Trametinib (GSK1120212): Precision MEK Inhibition in Tumor H

  2026-05-22

  Explore how Trametinib (GSK1120212) enables nuanced dissection of MEK-ERK pathway dynamics and therapeutic heterogeneity in cancer research. This article delivers advanced scientific context and practical guidance for leveraging Trametinib’s unique properties in complex, evolving tumor models.

• Acetoacetic Acid Sodium Salt: Precision Metabolic Modeling &

  2026-05-22

  Explore advanced strategies for using Acetoacetic acid sodium salt in precision energy metabolism research and diabetic ketoacidosis modeling. This article reveals unique protocol design insights and practical assay considerations for sodium 3-oxobutanoate, setting it apart from standard overviews.

• 3-Methyladenine: Optimizing Autophagy Research Workflows

  2026-05-21

  3-Methyladenine (3-MA) from APExBIO enables precise, reproducible control of autophagy for cancer and migration studies. This article delivers step-by-step protocol enhancements, troubleshooting guidance, and cross-study integration to empower experimental success.

• Thioguanine: Mechanistic Precision Driving Translational Imp

  2026-05-21

  Explore how Thioguanine (6-thioguanine) delivers targeted antitumor and antiviral action through dual inhibition of DNMT1 and HGPRT, bridging mechanistic insight and strategic translational guidance. This article moves beyond conventional product detail, synthesizing recent clinical and experimental findings to empower researchers with actionable, scenario-driven protocols and a forward-looking perspective on maximizing impact in oncology and virology.

• Cathepsin B Inhibitor CA-074: Technical Guidance for Researc

  2026-05-20

  Cathepsin B inhibitor CA-074 (SKU A1926) enables researchers to selectively block cathepsin B with nanomolar potency, supporting studies in cancer metastasis, neurotoxicity, and immune modulation. It is most applicable where reproducible, target-specific inhibition is required, but should not be used as a pan-cathepsin inhibitor or where long-term solution stability is critical.

• Cell-Type Specific Hepatic Uptake of PEGylated Iron Oxide Na

  2026-05-20

  This study systematically deciphers how nanoparticle size and PEG chain length control hepatic uptake and cellular distribution of iron oxide nanoparticles. By integrating in vivo imaging with primary liver cell assays, it challenges established models of hepatic clearance and offers new design principles for nanomedicines targeting the liver.

• Adenosine Triphosphate (ATP): Beyond Energy—Precision in Mit

  2026-05-19

  Explore how Adenosine triphosphate (ATP) advances mitochondrial metabolism research beyond its role as an energy carrier. This article uniquely dissects post-translational enzyme control and practical assay decisions, drawing from the latest molecular insights.

• Partial β-Secretase Inhibition Lowers Amyloid β Without Syna

  2026-05-19

  Satir et al. (2020) demonstrate that moderate inhibition of β-secretase (BACE) can reduce amyloid β (Aβ) production by up to 50% without impairing synaptic transmission in cultured neurons. This finding supports strategies targeting partial Aβ reduction for safer Alzheimer's disease intervention, and informs the design of future BACE inhibitor trials.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Protein Re

  2026-05-18

  This study uncovers a noncanonical role for the mitochondrial DNAJC co-chaperone TCAIM, which specifically binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels via HSPA9 and LONP1, thereby modulating mitochondrial metabolism. These findings reveal a new post-translational regulatory mechanism impacting the TCA cycle and cellular energy homeostasis, with implications for understanding metabolic control in health and disease.

• N1-Methyl-Pseudouridine-5'-Triphosphate in Inhaled RNA Thera

  2026-05-18

  Explore how N1-Methyl-Pseudouridine-5'-Triphosphate advances inhaled RNA therapeutics and tumor microenvironment modulation. This article delivers a unique, evidence-backed perspective for researchers seeking to optimize mRNA design for lung cancer immunotherapy.

• Epidermal Growth Factor: Applied Workflows and Research Insi

  2026-05-17

  APExBIO’s recombinant human EGF unlocks precision control over cell proliferation, migration, and mucosal healing in experimental models. This guide synthesizes advanced protocols, troubleshooting strategies, and key insights from recent research—empowering labs to design robust, high-impact studies.

519 records 6/35 page Previous Next First page 上5页 678910 下5页 Last page